Sleepio for adults with difficulty sleeping (MT443)
In development [GID-MT552] Expected publication date: 03 August 2021
In development [GID-MT552] Expected publication date: 03 August 2021
In development [GID-NG10135] Expected publication date: 02 March 2021
This guideline sets out an antimicrobial prescribing strategy for human and animal bites (excluding insect bites) in adults, young people and children aged 72 hours and over. It aims to optimise antibiotic use and reduce antibiotic resistance.
This guideline sets out an antimicrobial prescribing strategy for adults, young people and children aged 72 hours and over with impetigo. It aims to optimise antibiotic use and reduce antibiotic resistance.
This guideline sets out an antimicrobial prescribing strategy for acute cough associated with an upper respiratory tract infection or acute bronchitis in adults, young people and children. It aims to limit antibiotic use and reduce antibiotic resistance.
This guideline sets out an antimicrobial prescribing strategy for managing and preventing acute exacerbations of bronchiectasis (non-cystic fibrosis). It aims to optimise antibiotic use and reduce antibiotic resistance.
This guideline covers preventing and managing foot problems in children, young people and adults with diabetes. It aims to reduce variation in practice, including antibiotic prescribing for diabetic foot infections.
This guideline sets out an antimicrobial prescribing strategy for adults, young people, children and babies aged 72 hours and over with cellulitis and erysipelas. It aims to optimise antibiotic use and reduce antibiotic resistance.
This guideline sets out an antimicrobial prescribing strategy for community-acquired pneumonia. It aims to optimise antibiotic use and reduce antibiotic resistance.
This guideline sets out an antimicrobial prescribing strategy for acute exacerbations of chronic obstructive pulmonary disease (COPD). It aims to optimise antibiotic use and reduce antibiotic resistance.
This guideline sets out an antimicrobial prescribing strategy for catheter-associated urinary tract infection in children, young people and adults. It aims to optimise antibiotic use and reduce antibiotic resistance.
This guideline sets out an antimicrobial prescribing strategy for preventing recurrent urinary tract infections in children, young people and adults who do not have a catheter. It aims to optimise antibiotic use and reduce antibiotic resistance.
This guideline sets out an antimicrobial prescribing strategy for acute otitis media (ear infection). It aims to limit antibiotic use and reduce antimicrobial resistance. Acute otitis media can be caused by viruses or bacteria. It lasts for about a week, and most children get better in 3 days without antibiotics. Serious complications are rare.
This guideline sets out an antimicrobial prescribing strategy for acute sore throat. It aims to limit antibiotic use and reduce antimicrobial resistance. Acute sore throat is often caused by a virus, lasts for about a week, and most people get better without antibiotics. Withholding antibiotics rarely leads to complications.
This guideline sets out an antimicrobial prescribing strategy for acute pyelonephritis (upper urinary tract infection) in children, young people and adults who do not have a catheter. It aims to optimise antibiotic use and reduce antibiotic resistance.
This guideline sets out an antimicrobial prescribing strategy for acute prostatitis. It aims to optimise antibiotic use and reduce antibiotic resistance.
This guideline sets out an antimicrobial prescribing strategy for lower urinary tract infection (also called cystitis) in children, young people and adults who do not have a catheter. It aims to optimise antibiotic use and reduce antibiotic resistance.
This guideline sets out an antimicrobial prescribing strategy for adults with leg ulcer infection. It aims to optimise antibiotic use and reduce antibiotic resistance.
This guideline sets out an antimicrobial prescribing strategy for acute sinusitis. It aims to limit antibiotic use and reduce antimicrobial resistance. Acute sinusitis is usually caused by a virus, lasts for about 2 to 3 weeks, and most people get better without antibiotics. Withholding antibiotics rarely leads to complications.
This guideline sets out an antimicrobial prescribing strategy for insect and spider bites and stings in adults, young people and children aged 72 hours and over, including those that occurred while travelling outside the UK. It aims to limit antibiotic use and reduce antibiotic resistance.
This guideline sets out an antimicrobial prescribing strategy for hospital-acquired pneumonia. It does not cover ventilator-associated pneumonia. It aims to optimise antibiotic use and reduce antibiotic resistance.
In development [GID-NG10167] Expected publication date: TBC
In development [GID-NG10168] Expected publication date: TBC
In development [GID-NG10163] Expected publication date: TBC
In development [GID-NG10166] Expected publication date: TBC
In development [GID-NG10144] Expected publication date: 23 July 2021
In development [GID-IPG10138] Expected publication date: 03 March 2021
In development [GID-IPG10146] Expected publication date: 03 March 2021
In development [GID-MT539] Expected publication date: TBC
In development [GID-MT538] Expected publication date: TBC
In development [GID-MT544] Expected publication date: 15 September 2020
In development [GID-MT531] Expected publication date: TBC
In development [GID-MT559] Expected publication date: 19 January 2022
In development [GID-MT526] Expected publication date: TBC
In development [GID-MT551] Expected publication date: 05 October 2021
In development [GID-MT542] Expected publication date: 08 March 2021
In development [GID-MT554] Expected publication date: 06 January 2022
In development [GID-MT557] Expected publication date: 22 March 2022
In development [GID-MT561] Expected publication date: 02 February 2022
In development [GID-MT548] Expected publication date: 04 May 2021
In development [GID-MT550] Expected publication date: 04 October 2021
In development [GID-MT553] Expected publication date: 30 November 2021
In development [GID-MT558] Expected publication date: 09 November 2021
In development [GID-MT560] Expected publication date: 15 March 2022
In development [GID-MT556] Expected publication date: 23 February 2022
In development [GID-MT537] Expected publication date: 08 April 2021
In development [GID-TAG430] Expected publication date: 03 March 2021
In development [GID-TA10562] Expected publication date: 03 March 2021
Evidence-based recommendations on Leukomed Sorbact for preventing surgical site infection after caesarean section or vascular surgery
Evidence-based recommendations on SecurAcath for securing percutaneous catheters (central venous catheters/CVCs)